Safety and Clinical Efficacy of Rapidly-Generated Virus-Specific T Cells with Activity Against Adv, EBV, CMV, HHV6 and BK Virus Administered after Allogeneic Hematopoietic Stem Cell Transplant
2014 ◽
Vol 20
(2)
◽
pp. S48
◽
2013 ◽
Vol 19
(2)
◽
pp. S111
2011 ◽
Vol 17
(2)
◽
pp. S282-S283
2009 ◽
Vol 45
(3)
◽
pp. 543-549
◽
2019 ◽
Vol 25
(3)
◽
pp. S359-S360